Cresco Labs announces third quarter financial results release
The company will host an earnings conference call on November 6, 2026. A webcast registration link is available for investors.
See the latest news and media coverage for Cresco Labs. We track all announcements, press releases, and industry mentions in real time, all in one place.
Cannabis cultivator, manufacturer, distributor, and retailer
crescolabs.comLast updated
In short: Cresco Labs reported $173M Q2 revenue, set U.S.-listing vote, and closed $50M Pennsylvania deal.
The company will host an earnings conference call on November 6, 2026. A webcast registration link is available for investors.
The cash-free transaction strengthens its vertical integration and retail footprint while immediately boosting revenue, margins, and cash flow in a core medical cannabis market.
Adjusted EBITDA reached $40M with 22.8% margin, net income $15M, and CFO Sharon Schuler is stepping down.
Adjusted EBITDA reached $40 million with a 22.8% margin, and net income was $15 million, aided by a tax benefit.
Adjusted EBITDA reached USD 40 million, an increase of 20 percent from the prior quarter, while adjusted gross profit came to USD 89 million at...
Cresco Labs is asking holders to approve three changes on Oct. 30, including a share exchange and a possible move to Delaware ...
06.08. Cresco Labs Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026...
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”) today announced the closing of its acquisition of 100% of the...
Track Cresco Labs and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.